Role of OGR1 in myeloid-derived cells in prostate cancer

Yan Liu, L. S. Singh, L. Zhang, Yan Xu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Ovarian cancer G-protein-coupled-receptor-1 (OGR1) is a tumor metastasis suppressor in prostate cancer (PCa). OGR1 knockout mice (ogr1 -/-) are grossly normal under physiological conditions, however, reduced melanoma tumorigenesis has been observed, with the mechanisms of this reduction completely unknown. In this work, we demonstrated that OGR1 deficiency in host cells significantly reduced tumorigenesis of PCa in mice. Adoptive transfer of WT CD11b + Gr1 + double positive (DP) cells, but not T cells, was sufficient to allow tumor development in ogr1 -/- mice. The expression of an M1 macrophage marker, inducible nitric oxide synthase (iNOS) was higher and expression of an M2 macrophage marker, arginase-1 (Arg 1) was lower in tumors from ogr1 -/- mice compared with WT mice. Furthermore, coinjection of transgenic adenocarcinoma mouse prostate (TRAMP)-C2 cells with WT, but not ogr1 -/- macrophages, increased tumor incidence in ogr1 -/- mice. T-cell depletion experiments suggested that T cells were required for tumor rejection in ogr1 -/- mice, although OGR1 expression in T cells may not be necessary. In summary, the expression of OGR1 in myeloid-derived cells, especially in DP cells, was required for PCa tumor cell-induced immunosuppression.

Original languageEnglish
Pages (from-to)157-164
Number of pages8
JournalOncogene
Volume33
Issue number2
DOIs
StatePublished - Jan 9 2014

Fingerprint

Myeloid Cells
G-Protein-Coupled Receptors
Ovarian Neoplasms
Prostatic Neoplasms
T-Lymphocytes
Neoplasms
Macrophages
Carcinogenesis
Arginase
Adoptive Transfer
Nitric Oxide Synthase Type II
Knockout Mice
Immunosuppression
Transgenic Mice
Prostate
Melanoma
Adenocarcinoma
Neoplasm Metastasis
Incidence

Keywords

  • adoptive transfer
  • macrophages
  • MDSC
  • OGR1
  • ovarian cancer G protein coupled receptor-1

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Role of OGR1 in myeloid-derived cells in prostate cancer. / Liu, Yan; Singh, L. S.; Zhang, L.; Xu, Yan.

In: Oncogene, Vol. 33, No. 2, 09.01.2014, p. 157-164.

Research output: Contribution to journalArticle

Liu, Yan ; Singh, L. S. ; Zhang, L. ; Xu, Yan. / Role of OGR1 in myeloid-derived cells in prostate cancer. In: Oncogene. 2014 ; Vol. 33, No. 2. pp. 157-164.
@article{d2e5b50750a74ede96a58992db8d5727,
title = "Role of OGR1 in myeloid-derived cells in prostate cancer",
abstract = "Ovarian cancer G-protein-coupled-receptor-1 (OGR1) is a tumor metastasis suppressor in prostate cancer (PCa). OGR1 knockout mice (ogr1 -/-) are grossly normal under physiological conditions, however, reduced melanoma tumorigenesis has been observed, with the mechanisms of this reduction completely unknown. In this work, we demonstrated that OGR1 deficiency in host cells significantly reduced tumorigenesis of PCa in mice. Adoptive transfer of WT CD11b + Gr1 + double positive (DP) cells, but not T cells, was sufficient to allow tumor development in ogr1 -/- mice. The expression of an M1 macrophage marker, inducible nitric oxide synthase (iNOS) was higher and expression of an M2 macrophage marker, arginase-1 (Arg 1) was lower in tumors from ogr1 -/- mice compared with WT mice. Furthermore, coinjection of transgenic adenocarcinoma mouse prostate (TRAMP)-C2 cells with WT, but not ogr1 -/- macrophages, increased tumor incidence in ogr1 -/- mice. T-cell depletion experiments suggested that T cells were required for tumor rejection in ogr1 -/- mice, although OGR1 expression in T cells may not be necessary. In summary, the expression of OGR1 in myeloid-derived cells, especially in DP cells, was required for PCa tumor cell-induced immunosuppression.",
keywords = "adoptive transfer, macrophages, MDSC, OGR1, ovarian cancer G protein coupled receptor-1",
author = "Yan Liu and Singh, {L. S.} and L. Zhang and Yan Xu",
year = "2014",
month = "1",
day = "9",
doi = "10.1038/onc.2012.566",
language = "English",
volume = "33",
pages = "157--164",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Role of OGR1 in myeloid-derived cells in prostate cancer

AU - Liu, Yan

AU - Singh, L. S.

AU - Zhang, L.

AU - Xu, Yan

PY - 2014/1/9

Y1 - 2014/1/9

N2 - Ovarian cancer G-protein-coupled-receptor-1 (OGR1) is a tumor metastasis suppressor in prostate cancer (PCa). OGR1 knockout mice (ogr1 -/-) are grossly normal under physiological conditions, however, reduced melanoma tumorigenesis has been observed, with the mechanisms of this reduction completely unknown. In this work, we demonstrated that OGR1 deficiency in host cells significantly reduced tumorigenesis of PCa in mice. Adoptive transfer of WT CD11b + Gr1 + double positive (DP) cells, but not T cells, was sufficient to allow tumor development in ogr1 -/- mice. The expression of an M1 macrophage marker, inducible nitric oxide synthase (iNOS) was higher and expression of an M2 macrophage marker, arginase-1 (Arg 1) was lower in tumors from ogr1 -/- mice compared with WT mice. Furthermore, coinjection of transgenic adenocarcinoma mouse prostate (TRAMP)-C2 cells with WT, but not ogr1 -/- macrophages, increased tumor incidence in ogr1 -/- mice. T-cell depletion experiments suggested that T cells were required for tumor rejection in ogr1 -/- mice, although OGR1 expression in T cells may not be necessary. In summary, the expression of OGR1 in myeloid-derived cells, especially in DP cells, was required for PCa tumor cell-induced immunosuppression.

AB - Ovarian cancer G-protein-coupled-receptor-1 (OGR1) is a tumor metastasis suppressor in prostate cancer (PCa). OGR1 knockout mice (ogr1 -/-) are grossly normal under physiological conditions, however, reduced melanoma tumorigenesis has been observed, with the mechanisms of this reduction completely unknown. In this work, we demonstrated that OGR1 deficiency in host cells significantly reduced tumorigenesis of PCa in mice. Adoptive transfer of WT CD11b + Gr1 + double positive (DP) cells, but not T cells, was sufficient to allow tumor development in ogr1 -/- mice. The expression of an M1 macrophage marker, inducible nitric oxide synthase (iNOS) was higher and expression of an M2 macrophage marker, arginase-1 (Arg 1) was lower in tumors from ogr1 -/- mice compared with WT mice. Furthermore, coinjection of transgenic adenocarcinoma mouse prostate (TRAMP)-C2 cells with WT, but not ogr1 -/- macrophages, increased tumor incidence in ogr1 -/- mice. T-cell depletion experiments suggested that T cells were required for tumor rejection in ogr1 -/- mice, although OGR1 expression in T cells may not be necessary. In summary, the expression of OGR1 in myeloid-derived cells, especially in DP cells, was required for PCa tumor cell-induced immunosuppression.

KW - adoptive transfer

KW - macrophages

KW - MDSC

KW - OGR1

KW - ovarian cancer G protein coupled receptor-1

UR - http://www.scopus.com/inward/record.url?scp=84891911462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891911462&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.566

DO - 10.1038/onc.2012.566

M3 - Article

C2 - 23222714

AN - SCOPUS:84891911462

VL - 33

SP - 157

EP - 164

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 2

ER -